|
OMIM |
Link |
Information gain |
01 |
|
SPS
|
[NCBI]
|
0.0103272
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00631522
|
|
|
CVID
|
[NCBI]
|
0.00277672
|
|
|
MG
|
[NCBI]
|
0.00091288
|
|
|
RA
|
[NCBI]
|
0.000608291
|
|
|
CF
|
[NCBI]
|
0.000432617
|
|
|
kawasaki disease
|
[NCBI]
|
0.000274331
|
|
|
SLE
|
[NCBI]
|
0.000207517
|
|
|
HIGM1
|
[NCBI]
|
0.000135037
|
|
|
OCP
|
[NCBI]
|
0.000101159
|
|
|
LKS
|
[NCBI]
|
8.27355e-05
|
|
|
TNF
|
[NCBI]
|
7.03717e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
6.17676e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
5.21409e-05
|
|
|
LPI
|
[NCBI]
|
3.98063e-05
|
|
|
MAG
|
[NCBI]
|
3.97291e-05
|
|
|
AK5
|
[NCBI]
|
3.81257e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.63428e-05
|
|
|
IL23R
|
[NCBI]
|
2.9415e-05
|
|
|
TIMM8A
|
[NCBI]
|
2.66824e-05
|
|
|
FCGR2B
|
[NCBI]
|
2.66824e-05
|
|
|
SCIDX1
|
[NCBI]
|
2.66376e-05
|
|
|
MBP
|
[NCBI]
|
2.56736e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.32448e-05
|
|
|
MPL
|
[NCBI]
|
2.30906e-05
|
|
|
IL2RG
|
[NCBI]
|
2.26725e-05
|
|
|
MPO
|
[NCBI]
|
2.25885e-05
|
|
|
WAS
|
[NCBI]
|
2.20321e-05
|
|
|
IL12B
|
[NCBI]
|
2.11163e-05
|
|
|
TNFRSF6
|
[NCBI]
|
1.9798e-05
|
|
|
IGHG1
|
[NCBI]
|
1.89392e-05
|
|
|
THPO
|
[NCBI]
|
1.71183e-05
|
|
|
BTK
|
[NCBI]
|
1.6651e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.28581e-05
|
|
|
AGER
|
[NCBI]
|
1.27087e-05
|
|
|
ADA
|
[NCBI]
|
1.23334e-05
|
|
|
AT
|
[NCBI]
|
9.11387e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
8.74733e-06
|
|
|
OSM
|
[NCBI]
|
8.53226e-06
|
|
|
VEGF
|
[NCBI]
|
7.88987e-06
|
|
|
DBA
|
[NCBI]
|
7.69312e-06
|
|
|
EIG
|
[NCBI]
|
7.05532e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.90444e-06
|
|
|
PF4
|
[NCBI]
|
6.73006e-06
|
|
|
PYY
|
[NCBI]
|
6.04253e-06
|
|
|
ALPS
|
[NCBI]
|
5.53019e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
4.84528e-06
|
|
|
RNASE3
|
[NCBI]
|
4.41492e-06
|
|
|
F3
|
[NCBI]
|
1.99977e-06
|
|
|
NGFB
|
[NCBI]
|
9.13014e-07
|
|
|
ALD
|
[NCBI]
|
8.22175e-07
|
|
|
EPO
|
[NCBI]
|
2.55509e-07
|
|
|
CJD
|
[NCBI]
|
2.3706e-07
|
|